Our Blog

Pre-call prep time is a crucial part of any sales rep’s day, but healthcare sales have seen a renaissance of pre-call planning, and new challenges are being introduced as a result of this evolution.

Problems take shape as the pre-call planning process starts to consume more and more valuable selling time – something pharma sales reps (PSRs) can’t spare.

Today’s article explores the pre-call planning process for healthcare sales, and offers solutions for enhancing the process.

Social media is an essential channel for marketing communications. B2B and B2C companies have been using social media to connect and communicate with customers and stakeholders for years.

However, many pharma sales and marketing teams have been hesitant to use social media in their communication strategies. Fear of FDA regulations, legal requirements and public engagement, have left many scared to enter the social media environment, and engage with patients and healthcare providers (HCPs).

Throughout this article we will be discussing why pharma companies should be using social media, the biggest challenges of social media for pharma sales, why pharma companies are afraid of social media, and several strategies for success!

[Related content] Our next post is an infographic explaining how using social media can benefit pharma companies. 

The daily life of the pharma sales reps involves spending a lot of time on non-selling activities; this includes struggling with 3 major challenges of pharma sales and marketing content creation and use.

Previously we discussed the types of content that healthcare providers (HCPs) desire from pharma sales and marketing. They are desperate for digital content, evidence-based information, and regulatory compliance. HCPs place a high value on authentic sources.

The 3 major pharma sales rep (PSR) challenges of creating and using pharma sales content are information complexity, geography, and industry regulations. Today’s article explores these hurdles and offers solutions to help improve the life of the pharmaceutical sales reps.

The move towards value-based, personalized healthcare means that life science and pharma companies need to create conversations around evidence and efficiency, rather than traditional promotional materials.

Pharma can extend their value proposition by moving ‘beyond the pill’ and embracing an end-to-end (E2E) evidence tactic. This model involves providing evidence across the entire product life cycle.

Healthcare providers (HCPs) favour this model because it focuses on real world outcomes, providing them with trustworthy and authentic information. For more information on this visit our previous post and infographic explaining what HCPs want from pharma.

This week we've been discussing what healthcare providers want from pharma sales and marketing (Part 1 and Part 2).

Pharma sales reps and healthcare providers need to form partnerships. They must work together to provide value and achieve their shared goal of improving patient care and outcomes. Pharma companies can achieve this by rethinking how they support, communicate, and coordinate with HCPs.

We've created an infographic highlighting the important ideas and aspects from each area of AUTHENTICITY. 

Today’s article is Part 2 of our mini series exploring what healthcare providers desire from their pharma industry counterparts.

In Part 1 we discussed how healthcare providers (HCPs) want pharmaceutical sales reps (PSRs) to, raise awareness about disease, improve their understanding of patients’ lives, create treatment packages, help with research to educate doctors on rare diseases, provide education for patients and physicians, and produce new drugs and data.

The information found here is based upon Eye for Pharma’s excellent 2015 whitepaper “HCPs: We Want Partnerships with Pharma”, where they surveyed 549 HCPs from various specialities. Asking them ‘what can pharma do to improve patient care?’

We are calling it AUTHENTICITY.

There’s a lot of emphasis on the need for partnerships between pharma and physicians. They must work together to provide value and accomplish their shared goal of improving patient care and outcomes. Pharma companies can achieve this by rethinking how they plan, launch, support, communicate, and coordinate with healthcare providers (HCPs).

In their 2015 whitepaper “HCPs: We Want Partnerships with Pharma”, Eyeforpharma details the changes affecting the relationship between the two parties. They surveyed 549 HCPs from various specialities. Asking them ‘what can pharma do to improve patient care?’

Today’s article is Part 1 of a 2-part series exploring what healthcare providers desire from their pharma industry counterparts.

We are calling it AUTHENTICITY.